MoonLake Immunotherapeutics Increase Decrease In Operating Lease Liability
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- MoonLake Immunotherapeutics increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$395.00K.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$389.00K.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$377.00K.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$401.00K.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for fiscal 2025 was -$1.22M.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for fiscal 2024 was -$1.42M.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for fiscal 2023 was -$222.00K.
- MoonLake Immunotherapeutics increase decrease in operating lease liability for fiscal 2022 was -$152.43K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$395.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$784.00K 10-Q · filed 2026-08-10 | -$1.16M derived: sum of 3 quarters · filed 2026-08-10 | -$1.56M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$389.00K 10-Q · filed 2026-05-11 | -$766.00K derived: sum of 2 quarters · filed 2026-05-11 | -$1.17M derived: sum of 3 quarters · filed 2026-05-11 | -$1.36M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$778.00K derived: sum of 2 quarters · filed 2026-02-25 | -$967.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.22M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$590.00K derived: sum of 2 quarters · filed 2026-08-10 | -$845.00K 10-Q · filed 2025-11-05 | -$1.40M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$444.00K 10-Q · filed 2026-08-10 | -$995.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.14M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$255.00K 10-Q · filed 2026-05-11 | -$806.00K derived: sum of 2 quarters · filed 2026-05-11 | -$955.00K derived: sum of 3 quarters · filed 2026-05-11 | -$1.27M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$700.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.02M derived: sum of 3 quarters · filed 2026-02-25 | -$1.42M 10-K · filed 2026-02-25 | -$1.42M 10-K · filed 2025-02-26 | |||
| 2024-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$466.00K derived: sum of 2 quarters · filed 2025-11-05 | -$872.00K 10-Q · filed 2025-11-05 | -$872.12K 10-Q · filed 2024-11-07 | -$976.17K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | -$317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$723.00K 10-Q · filed 2025-08-05 | -$723.49K 10-Q · filed 2024-08-07 | -$827.17K derived: sum of 3 quarters · filed 2026-02-25 | -$866.73K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | -$406.00K 10-Q · filed 2025-05-12 | -$405.57K 10-Q · filed 2024-05-07 | -$510.17K derived: sum of 2 quarters · filed 2026-02-25 | -$549.73K derived: sum of 3 quarters · filed 2026-02-25 | -$589.17K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | -$104.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$143.73K derived: sum of 2 quarters · filed 2026-02-25 | -$183.18K derived: sum of 3 quarters · filed 2026-02-25 | -$222.00K 10-K · filed 2026-02-25 | -$222.26K 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$39.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$79.01K derived: sum of 2 quarters · filed 2024-11-07 | -$117.83K 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | -$39.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$78.27K 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | -$38.83K 10-Q · filed 2024-05-07 | |||||||
| 2022-12-31 | -$152.43K 10-K · filed 2025-02-26 |